FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310447940> ?p ?o ?g. }

• W4310447940 abstract "Abstract Background Acute lung injury (ALI) arises from sepsis or bacterial infection, which are life-threatening respiratory disorders that cause the leading cause of death worldwide. 5-Methoxyflavone, a methylated flavonoid, is gaining increased attention for its various health benefits. In the current study, we investigated the potential effects of 5-methoxyflavone against LPS-mediated ALI and elucidated the corresponding possible mechanism. Methods A mouse model with ALI was established by intratracheal instillation of LPS, and lung pathological changes, signaling pathway related proteins and apoptosis in lung tissues were estimated by H&E staining, immunofluorescence and TUNEL assay, respectively. Cell viability was evaluated by MTT assay; protein levels of pro-inflammatory mediators were measured by ELISA assay; levels of ROS and M1 macrophage polarization were assayed by flow cytometry; the expression of Nrf2 signaling, NOX4/TLR4 axis and P-STAT1 were detected by western blotting. Results Our results showed that 5-methoxyflavone treatment inhibited LPS-induced expression of NOX4 and TLR4 as well as the activation of downstream signaling (NF-κB and P38 MAPK), which was accompanied by markedly decreased ROS levels and pro-inflammatory cytokines (IL-6, TNF-α, MCP-1, and IL-8) in BEAS-2B cells. Moreover, we revealed that these effects of 5-methoxyflavone were related to its Nrf2 activating property, and blockade of Nrf2 prevented its inhibitory effects on NOX4/TLR4/NF-κB/P38 MAPK signaling, thus abrogating the anti-inflammatory effects of 5-methoxyflavone. Besides, the Nrf2 activating property of 5-methoxyflavone in RAW264.7 cells led to inhibition of LPS/IFN-γ-mediated STAT1 signaling, resulting in suppression of LPS/IFN-γ-induced M1 macrophage polarization and the repolarization of M2 macrophages to M1. In a mouse model of LPS-induced ALI, 5-methoxyflavone administration ameliorated LPS-mediated lung pathological changes, the increased lung index (lung/body weight ratio), and epithelial cell apoptosis. Meanwhile, we found 5-methoxyflavone effectively suppressed the hyperactive signaling pathways and the production of excessive pro-inflammatory mediators. Moreover, 5-methoxyflavone reduced LPS-mediated M1 macrophage polarization associated with elevated P-STAT1 activation in the lung tissues. In addition, 5-methoxyflavone improved the survival of LPS-challenged mice. Conclusion These results indicated that 5-methoxyflavone might be suitable for the development of a novel drug for ALI therapeutic." @default.
• W4310447940 created "2022-12-10" @default.
• W4310447940 creator A5000758677 @default.
• W4310447940 creator A5012677271 @default.
• W4310447940 creator A5022921578 @default.
• W4310447940 creator A5044687255 @default.
• W4310447940 creator A5047272920 @default.
• W4310447940 creator A5067160853 @default.
• W4310447940 creator A5073214929 @default.
• W4310447940 creator A5074391214 @default.
• W4310447940 creator A5084622026 @default.
• W4310447940 date "2022-11-30" @default.
• W4310447940 modified "2023-10-18" @default.
• W4310447940 title "5-Methoxyflavone alleviates LPS-mediated lung injury by promoting Nrf2-mediated the suppression of NOX4/TLR4 axis in bronchial epithelial cells and M1 polarization in macrophages" @default.
• W4310447940 cites W1490878570 @default.
• W4310447940 cites W1803645748 @default.
• W4310447940 cites W1988197310 @default.
• W4310447940 cites W2009527138 @default.
• W4310447940 cites W2033147946 @default.
• W4310447940 cites W2047462308 @default.
• W4310447940 cites W2068854215 @default.
• W4310447940 cites W2070855360 @default.
• W4310447940 cites W2092629458 @default.
• W4310447940 cites W2096261918 @default.
• W4310447940 cites W2102910971 @default.
• W4310447940 cites W2106248075 @default.
• W4310447940 cites W2106307355 @default.
• W4310447940 cites W2123303185 @default.
• W4310447940 cites W2136506501 @default.
• W4310447940 cites W2137894554 @default.
• W4310447940 cites W2140079450 @default.
• W4310447940 cites W2156551852 @default.
• W4310447940 cites W2178317029 @default.
• W4310447940 cites W2266938879 @default.
• W4310447940 cites W2284142123 @default.
• W4310447940 cites W2342612813 @default.
• W4310447940 cites W2400239628 @default.
• W4310447940 cites W2530726117 @default.
• W4310447940 cites W2613483874 @default.
• W4310447940 cites W2616814628 @default.
• W4310447940 cites W2620241325 @default.
• W4310447940 cites W2765948467 @default.
• W4310447940 cites W2793866905 @default.
• W4310447940 cites W2800590854 @default.
• W4310447940 cites W2802534073 @default.
• W4310447940 cites W2802595885 @default.
• W4310447940 cites W2807906301 @default.
• W4310447940 cites W2889565370 @default.
• W4310447940 cites W2896612342 @default.
• W4310447940 cites W2897143284 @default.
• W4310447940 cites W2954102268 @default.
• W4310447940 cites W2955294901 @default.
• W4310447940 cites W2975823818 @default.
• W4310447940 cites W3019785310 @default.
• W4310447940 cites W3022610088 @default.
• W4310447940 cites W3041595964 @default.
• W4310447940 cites W3041738119 @default.
• W4310447940 cites W3047284551 @default.
• W4310447940 cites W3087374704 @default.
• W4310447940 cites W3103525962 @default.
• W4310447940 cites W3110586950 @default.
• W4310447940 cites W3112214349 @default.
• W4310447940 cites W3128314102 @default.
• W4310447940 cites W3166824233 @default.
• W4310447940 cites W3203015639 @default.
• W4310447940 cites W4206764679 @default.
• W4310447940 cites W4210287286 @default.
• W4310447940 cites W4211250103 @default.
• W4310447940 cites W4214676446 @default.
• W4310447940 doi "https://doi.org/10.1186/s12950-022-00319-6" @default.
• W4310447940 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36451220" @default.
• W4310447940 hasPublicationYear "2022" @default.
• W4310447940 type Work @default.
• W4310447940 citedByCount "1" @default.
• W4310447940 countsByYear W43104479402023 @default.
• W4310447940 crossrefType "journal-article" @default.
• W4310447940 hasAuthorship W4310447940A5000758677 @default.
• W4310447940 hasAuthorship W4310447940A5012677271 @default.
• W4310447940 hasAuthorship W4310447940A5022921578 @default.
• W4310447940 hasAuthorship W4310447940A5044687255 @default.
• W4310447940 hasAuthorship W4310447940A5047272920 @default.
• W4310447940 hasAuthorship W4310447940A5067160853 @default.
• W4310447940 hasAuthorship W4310447940A5073214929 @default.
• W4310447940 hasAuthorship W4310447940A5074391214 @default.
• W4310447940 hasAuthorship W4310447940A5084622026 @default.
• W4310447940 hasBestOaLocation W43104479401 @default.
• W4310447940 hasConcept C126322002 @default.
• W4310447940 hasConcept C185592680 @default.
• W4310447940 hasConcept C190283241 @default.
• W4310447940 hasConcept C196795494 @default.
• W4310447940 hasConcept C203014093 @default.
• W4310447940 hasConcept C204232928 @default.
• W4310447940 hasConcept C2776070231 @default.
• W4310447940 hasConcept C2776151105 @default.
• W4310447940 hasConcept C2776914184 @default.
• W4310447940 hasConcept C2777714996 @default.
• W4310447940 hasConcept C2777961210 @default.
• W4310447940 hasConcept C2779719074 @default.
• W4310447940 hasConcept C2779765511 @default.
• W4310447940 hasConcept C51551487 @default.

• next